Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 18/20 | 0.41 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.36 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.36 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.36 |
| ▸ | MAP4K1 | Q92918 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5628849 | 1.00 | F10 (0.41) | F10PIK3CDPIK3CAPIK3CGMAP4K1 | |
| SCHEMBL5628539 | 0.91 | F10 (0.43) | F10 | |
| SCHEMBL5626416 | 0.91 | F10 (0.43) | F10 | |
| SCHEMBL5629083 | 0.91 | F10 (0.44) | F10 | |
| SCHEMBL5626146 | 0.91 | F10 (0.44) | F10 | |
| SCHEMBL5624555 | 0.90 | F10 (0.42) | F10PIK3CDPIK3CAPIK3CGMAP4K1 | |
| SCHEMBL5626350 | 0.90 | F10 (0.42) | F10PIK3CDPIK3CAPIK3CGMAP4K1 | |
| SCHEMBL5626331 | 0.89 | F10 (0.46) | F10 | |
| SCHEMBL5626195 | 0.89 | F10 (0.46) | F10 | |
| SCHEMBL5628357 | 0.89 | F10 (0.44) | F10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070179122-A1 | Beta-Aminoacid-Derivatives As Factor Xa Inhibitors | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2007-08-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070179122-A1 | Beta-Aminoacid-Derivatives As Factor Xa Inhibitors | F12, F11, F5 | F10 9/4885PIK3CD 2590/4885PIK3CA 1361/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.